Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
While it can indirectly influence hormonal balance through weight loss, there is no direct evidence suggesting it directly affects the menstrual cycle
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
Notably, CoverMyMeds is the only PA vendor identified on the form, suggesting that it may be the program's exclusive electronic PA platform
If side effects remain intolerable after 8 weeks at a stable dose, switching to the alternative medication (tirzepatide to semaglutide or vice versa) is a reasonable clinical option
Methods in cell separations
US$ 27.56
US$ 21.79
US$ 23.71
